Longboard Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Longboard Pharmaceuticals, Inc.
CIK #0001832168
EDGAR Form CIK 2011 - 2024
10-K [0001832168]
10-Q [0001832168]
3 [0001832168]
4 [0001832168]
8-K [0001832168]
D [0001832168]
SC 13D [0001832168]
SC 13G [0001832168]
Form 13D/13G Filer Form 13D/13G Subject Filed
Viking Global Investors LP Longboard Pharmaceuticals Inc [2024-07-15]
RA Capital Management LP Longboard Pharmaceuticals Inc [2024-01-12]
ProSight Management LP Longboard Pharmaceuticals Inc [2023-04-20]
Point72 Asset Management LP Longboard Pharmaceuticals Inc [2023-02-14]
Pfizer Inc Longboard Pharmaceuticals Inc [2022-03-21]
Arena Pharmaceuticals Inc Longboard Pharmaceuticals Inc [2022-03-10]
Integrated Core Strategies US LLC Longboard Pharmaceuticals Inc [2022-01-12]
FMR LLC Longboard Pharmaceuticals Inc [2021-04-12]
Price T Rowe Associates Inc /MD/ Longboard Pharmaceuticals Inc [2021-04-12]
Cormorant Asset Management LP Longboard Pharmaceuticals Inc [2021-03-26]
View All
Form 3/4/5 Subject 2011 - 2024
Longboard Pharmaceuticals, Inc.
Kaye Randall
Lind Kevin Robert
Lynch Casey
Schneider Phillip M
Sekhri Paul J
Aurentz Vincent
Le Goff Corinne
Roberts Brandi
Arena Pharmaceuticals Inc
View All
Terms | Privacy | Guide
tony@aum13f.com